Rituxipan 100mg Injection contains rituximab, a monoclonal antibody used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases like rheumatoid arthritis and certain rare inflammatory conditions. It works by targeting specific immune (B) cells involved in disease progression, helping control abnormal cell growth and immune activity.
Rituxipan 100mg Injection is administered as an intravenous (IV) infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule are tailored to the patient’s medical condition and response to therapy. Since the benefits may take time to appear, it is important to follow your doctor’s instructions and complete the full course of treatment.
Common side effects of Rituxipan include headache, weakness, infections, itching, diarrhea, and changes in blood pressure. Serious infusion-related reactions may occur during or shortly after administration and require immediate medical attention. Inform your doctor about any existing medical conditions before starting treatment. This medicine is not recommended during pregnancy or breastfeeding, and regular blood tests are required to monitor safety during therapy.
Rituxipan 100mg Injection contains rituximab, a monoclonal antibody that targets the CD20 antigen on B-lymphocytes, a type of white blood cell involved in immune function and certain cancers. It works by attaching to these B-cells and destroying them through multiple mechanisms, including activating the immune system to kill the marked cells, triggering the body’s complement system to break them down, and inducing programmed cell death (apoptosis). By eliminating abnormal or overactive B-cells, Rituxipan helps effectively treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune conditions such as rheumatoid arthritis, making it a key therapy in cancer and immune disorder management.
Side Effects of Rituxipan 100mg Injection
Like all medications, Rituxipan 100mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Rituxipan 100mg Injection is administered as an intravenous infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule vary depending on the indication, patient’s body surface area, and clinical condition. It may be used alone or in combination with chemotherapy for cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, or in defined regimens for autoimmune disorders like rheumatoid arthritis. The exact dosage and duration are determined by the prescribing physician.
Rituxipan 100mg Injection (rituximab) is not recommended during breastfeeding. Rituximab may pass into breast milk and could harm the nursing infant. Breastfeeding should be avoided during treatment and for at least 6 months after the last dose. Patients are advised to consult their physician for further guidance before resuming breastfeeding.
There is no clear evidence on the interaction between rituximab and alcohol. However, patients are advised to consult their doctor before consuming alcohol during treatment.
Rituxipan 100mg Injection may rarely cause serious lung problems, including pneumonitis or breathing difficulties. Patients with lung conditions should use it cautiously and report symptoms like cough, shortness of breath, or chest tightness to their doctor immediately.
Rituxipan 100mg Injection may cause fatigue, dizziness, or other side effects that can affect alertness. Patients should avoid driving or operating machinery if they experience these symptoms.
Rituxipan 100mg Injection should be avoided during pregnancy unless clearly needed. Rituximab may harm the unborn baby. Women of childbearing potential should use effective contraception during treatment and for 12 months after the last dose.
Rituxipan 100mg Injection is used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases including rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.
Rituxipan is administered as an intravenous (IV) infusion by a qualified healthcare professional in a hospital or clinical setting.
No, Rituxipan should not be used during an active or serious infection. Inform your doctor about any ongoing or past infections before starting treatment.
Common side effects include headache, weakness, fever, rash, diarrhea, dizziness, swelling, and infections. Most side effects are manageable with medical supervision.
Yes, serious risks may include severe infusion reactions, hepatitis B reactivation, low blood cell counts, and serious infections. Seek immediate medical attention if you notice unusual symptoms.
Live vaccines should be avoided during and after Rituxipan treatment, as the medicine can weaken the immune system.
No, Rituxipan is not recommended during pregnancy or breastfeeding. Effective contraception should be used during treatment and for 12 months after the last dose.
The treatment response varies by condition. Improvement may take several weeks or even months after starting Rituxipan therapy.
Yes, regular blood tests are needed to monitor blood cell levels, liver function, and screen for infections such as hepatitis B.
No, do not stop Rituxipan treatment without consulting your doctor. Stopping treatment suddenly may worsen your condition or reduce treatment effectiveness.
| Active ingredient | Rituximab |
| Pharmacologic class | Anti-CD20 monoclonal antibodies |
| Medication category | Antineoplastics Agent,(DMARDs) Disease-Modifying Antirheumatic Drugs. |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Rituxipan 100mg Injection contains rituximab, a monoclonal antibody used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases like rheumatoid arthritis and certain rare inflammatory conditions. It works by targeting specific immune (B) cells involved in disease progression, helping control abnormal cell growth and immune activity.
Rituxipan 100mg Injection is administered as an intravenous (IV) infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule are tailored to the patient’s medical condition and response to therapy. Since the benefits may take time to appear, it is important to follow your doctor’s instructions and complete the full course of treatment.
Common side effects of Rituxipan include headache, weakness, infections, itching, diarrhea, and changes in blood pressure. Serious infusion-related reactions may occur during or shortly after administration and require immediate medical attention. Inform your doctor about any existing medical conditions before starting treatment. This medicine is not recommended during pregnancy or breastfeeding, and regular blood tests are required to monitor safety during therapy.
Rituxipan 100mg Injection contains rituximab, a monoclonal antibody that targets the CD20 antigen on B-lymphocytes, a type of white blood cell involved in immune function and certain cancers. It works by attaching to these B-cells and destroying them through multiple mechanisms, including activating the immune system to kill the marked cells, triggering the body’s complement system to break them down, and inducing programmed cell death (apoptosis). By eliminating abnormal or overactive B-cells, Rituxipan helps effectively treat non-Hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune conditions such as rheumatoid arthritis, making it a key therapy in cancer and immune disorder management.
Side Effects of Rituxipan 100mg Injection
Like all medications, Rituxipan 100mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Rituxipan 100mg Injection is administered as an intravenous infusion under the supervision of a qualified healthcare professional. The dosage and treatment schedule vary depending on the indication, patient’s body surface area, and clinical condition. It may be used alone or in combination with chemotherapy for cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, or in defined regimens for autoimmune disorders like rheumatoid arthritis. The exact dosage and duration are determined by the prescribing physician.
Rituxipan 100mg Injection (rituximab) is not recommended during breastfeeding. Rituximab may pass into breast milk and could harm the nursing infant. Breastfeeding should be avoided during treatment and for at least 6 months after the last dose. Patients are advised to consult their physician for further guidance before resuming breastfeeding.
There is no clear evidence on the interaction between rituximab and alcohol. However, patients are advised to consult their doctor before consuming alcohol during treatment.
Rituxipan 100mg Injection may rarely cause serious lung problems, including pneumonitis or breathing difficulties. Patients with lung conditions should use it cautiously and report symptoms like cough, shortness of breath, or chest tightness to their doctor immediately.
Rituxipan 100mg Injection may cause fatigue, dizziness, or other side effects that can affect alertness. Patients should avoid driving or operating machinery if they experience these symptoms.
Rituxipan 100mg Injection should be avoided during pregnancy unless clearly needed. Rituximab may harm the unborn baby. Women of childbearing potential should use effective contraception during treatment and for 12 months after the last dose.
Rituxipan 100mg Injection is used to treat blood cancers such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as autoimmune diseases including rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.
Rituxipan is administered as an intravenous (IV) infusion by a qualified healthcare professional in a hospital or clinical setting.
No, Rituxipan should not be used during an active or serious infection. Inform your doctor about any ongoing or past infections before starting treatment.
Common side effects include headache, weakness, fever, rash, diarrhea, dizziness, swelling, and infections. Most side effects are manageable with medical supervision.
Yes, serious risks may include severe infusion reactions, hepatitis B reactivation, low blood cell counts, and serious infections. Seek immediate medical attention if you notice unusual symptoms.
Live vaccines should be avoided during and after Rituxipan treatment, as the medicine can weaken the immune system.
No, Rituxipan is not recommended during pregnancy or breastfeeding. Effective contraception should be used during treatment and for 12 months after the last dose.
The treatment response varies by condition. Improvement may take several weeks or even months after starting Rituxipan therapy.
Yes, regular blood tests are needed to monitor blood cell levels, liver function, and screen for infections such as hepatitis B.
No, do not stop Rituxipan treatment without consulting your doctor. Stopping treatment suddenly may worsen your condition or reduce treatment effectiveness.
| Active ingredient | Rituximab |
| Pharmacologic class | Anti-CD20 monoclonal antibodies |
| Medication category | Antineoplastics Agent,(DMARDs) Disease-Modifying Antirheumatic Drugs. |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
